Healthcare provider profile · identity verified

Nicholas John Modjeski, MD

Family Practice · WINONA, MN · NPI 1912933516

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	919	227
Amlodipine Besylate	Amlodipine Besylate	832	199
Simvastatin	Simvastatin	529	130
Losartan Potassium	Losartan Potassium	521	127
Metoprolol Succinate	Metoprolol Succinate	496	123
Lisinopril	Lisinopril	477	122
Warfarin Sodium	Warfarin Sodium	389	41
Metformin Hcl Er	Metformin Hcl	369	85
Omeprazole	Omeprazole	359	86
Eliquis	Apixaban	322	40
Hydrochlorothiazide	Hydrochlorothiazide	288	77
Levothyroxine Sodium	Levothyroxine Sodium	288	53
Sertraline Hcl	Sertraline Hcl	287	42
Tamsulosin Hcl	Tamsulosin Hcl	279	67
Rosuvastatin Calcium	Rosuvastatin Calcium	246	65
Furosemide	Furosemide	239	57
Gabapentin	Gabapentin	227	48
Tramadol Hcl	Tramadol Hcl	223	39
Potassium Chloride	Potassium Chloride	199	41
Pantoprazole Sodium	Pantoprazole Sodium	187	37
Metoprolol Tartrate	Metoprolol Tartrate	166	36
Metformin Hcl	Metformin Hcl	150	37
Finasteride	Finasteride	143	33
Fluticasone Propionate	Fluticasone Propionate	140	46
Allopurinol	Allopurinol	135	30
Doxazosin Mesylate	Doxazosin Mesylate	134	30
Chlorthalidone	Chlorthalidone	132	44
Xarelto	Rivaroxaban	132	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	129	32
Trulicity	Dulaglutide	128	25
Donepezil Hcl	Donepezil Hcl	123	23
Oxycodone Hcl	Oxycodone Hcl	116	17
Famotidine	Famotidine	115	22
Pregabalin	Pregabalin	107	22
Pravastatin Sodium	Pravastatin Sodium	93	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	12
Bupropion Xl	Bupropion Hcl	86	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	81	17
Mirtazapine	Mirtazapine	73	11
Carvedilol	Carvedilol	72	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	19
Ozempic	Semaglutide	69	19
Albuterol Sulfate Hfa	Albuterol Sulfate	66	27
Carbidopa-Levodopa	Carbidopa/Levodopa	66	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	65	31
Trazodone Hcl	Trazodone Hcl	63	18
Ezetimibe	Ezetimibe	62	20
Venlafaxine Hcl Er	Venlafaxine Hcl	62	suppressed
Montelukast Sodium	Montelukast Sodium	60	17
Diclofenac Sodium	Diclofenac Sodium	59	12
Jardiance	Empagliflozin	55	13
Alendronate Sodium	Alendronate Sodium	52	18
Glipizide Er	Glipizide	51	13
Januvia	Sitagliptin Phosphate	51	suppressed
Memantine Hcl	Memantine Hcl	50	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	14
Spironolactone	Spironolactone	47	15
Atenolol	Atenolol	46	13
Ramipril	Ramipril	46	suppressed
Nitroglycerin	Nitroglycerin	45	31
Citalopram Hbr	Citalopram Hydrobromide	44	16
Escitalopram Oxalate	Escitalopram Oxalate	43	11
Lamotrigine	Lamotrigine	43	suppressed
Ondansetron Odt	Ondansetron	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	11
Humalog Kwikpen U-100	Insulin Lispro	37	12
Levetiracetam	Levetiracetam	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	35	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Torsemide	Torsemide	33	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	32	32
Novolog Flexpen	Insulin Aspart	32	15
Prednisone	Prednisone	32	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	31	22
Mounjaro	Tirzepatide	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Phenobarbital	Phenobarbital	29	suppressed
Bumetanide	Bumetanide	27	suppressed
Latanoprost	Latanoprost	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	17
Buspirone Hcl	Buspirone Hcl	26	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Nystatin	Nystatin	26	14
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Cephalexin	Cephalexin	25	11
Clonazepam	Clonazepam	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	22	22
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Mometasone Furoate	Mometasone Furoate	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Potassium Citrate Er	Potassium Citrate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Cimetidine	Cimetidine	17	suppressed
Desmopressin Acetate	Desmopressin Acetate	17	suppressed
Glycopyrrolate	Glycopyrrolate	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	16
Entresto	Sacubitril/Valsartan	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Temazepam	Temazepam	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Azithromycin	Azithromycin	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Excilon	Non-Adherent Bandage	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Levetiracetam Er	Levetiracetam	13	suppressed
Methenamine Mandelate	Methenamine Mandelate	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nystop	Nystatin	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Emgality Pen	Galcanezumab-Gnlm	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error